Skip to main content

Pulse Biosciences, Inc.

PLSE
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001625101

In the last 90 days, Pulse Biosciences, Inc. insiders filed 2 open-market purchases and 0 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $297.0M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Pulse Biosciences, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of PLSE: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders55244−9
Shares4.22M28.0K3.07M−1.13M (−26.9%)
Value$20.5M$136.0K$4.66M−$15.7M (−77.2%)

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (10)

Institutions that held Pulse Biosciences, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to PLSE in Q2 2022
InstitutionSharesValue% of portfolio
Millennium Management LLC120,336$184.0K0.00%
Ergoteles LLC64,683$99.0K0.00%
Citadel Advisors LLC63,401$97.0K0.00%
Tiaa, FSB27,298$42.0K0.00%
Schonfeld Strategic Advisors LLC26,300$40.0K0.00%
Qube Research & Technologies Ltd13,277$20.0K0.00%
Boothbay Fund Management, LLC12,274$19.0K0.00%
Alpine Global Management, LLC12,274$19.0K0.00%
Simplex Trading, LLC1,474$2.00K0.00%
Credit Suisse AG7$00.00%

Sold out (19)

Institutions that held Pulse Biosciences, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Not filed for Q2 2022 yet (2)

Institutions that held Pulse Biosciences, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PLSE in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Parametric Portfolio Associates LLC25,714$125.0K
Amalgamated Financial Corp.2,273$11.0K